The EMA's Pharmacovigilance Risk Assessment Committee (PRAC), the key European body responsible for investigating safety concerns of member states, has issued new recommendations including safety warnings for widely used, anti-inflammatory drug diclofenac.
Following an investigation by the PRAC into cardiovascular risks associated with the use of pain relief medicine diclofenac, at the...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
